Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Pediatrix Medical (MD)

Pediatrix Q4 net income $30.5 million vs prior-year loss; 2024 net loss widens

Mixed Impact 3 of 5 earnings Written later

Pediatrix Medical Group reported fourth-quarter 2024 net income of $30.5 million, or $0.36 per diluted share, compared with a net loss of $124.3 million a year earlier, on net revenue of $502.4 million. For the full year, revenue rose to $2.01 billion, but the net loss widened to $99.1 million, and the company gave a preliminary 2025 Adjusted EBITDA range of $215 million to $235 million. Shareholders face mixed signals: a stronger quarter after portfolio exits, alongside a larger full-year loss that included $64.3 million in transformational and restructuring expenses.

Key points

  • Q4 2024 net revenue was $502.4 million, up from $496.4 million; net income was $30.5 million, or $0.36 per diluted share, versus a net loss of $124.3 million, or $1.50 per share, in Q4 2023.
  • Full-year 2024 net loss was $99.1 million, or $1.19 per share, compared with $60.4 million, or $0.73 per share, in 2023; full-year Adjusted EBITDA was $224.0 million versus $200.4 million.
  • Preliminary 2025 Adjusted EBITDA is expected to be in a range of $215 million to $235 million.
  • Total debt was $616 million at December 31, 2024, and cash and cash equivalents were $229.9 million.

The filing

CompanyPediatrix Medical (MD)
Form8-K, current report
Filed with the SECFeb 20, 2025, 6:50 AM ET
Accession number0000950170-25-023723

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.